Form 4: ATAI Life Sciences Executive Sells Shares to Cover Tax Obligations

Florian Brand, Co-Founder & CEO of ATAI Life Sciences N.V., sold 151,303 common shares to cover tax liabilities arising from the vesting of restricted stock units.

Summary

• On May 16, 2024, Florian Brand, Co-Founder & CEO of ATAI Life Sciences N.V., sold 151,303 common shares.
• The shares were sold at a price of $1.92 per share.
• The sale was executed to satisfy the reporting person's tax liability on the vesting of restricted stock units.
• Following the transaction, Brand directly owns 328,697 common shares and indirectly owns 2,333 common shares through his spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations, with no indication of a change in the executive's long-term confidence in the company.

Industry Context

Sales of shares by company executives are a common occurrence, often related to compensation and tax planning. The market typically assesses these sales based on their size and the executive's stated reasons.

Stakeholder Impact

• The sale of shares could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the stated reason for the sale.

Key Dates